GOSH
Sponsor study identifier
Secondary identifiers
REGISTRY · QMUL R and D
OTHER · UK REC
interventional
50
1 country
2
Study Start
December 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2018
Actual (reported)Study Completion
December 2019
Actual (reported)Title: Investigation of neutrophil defects associated with periodontal disease and tooth loss in children. A clinical study. Objectives: The primary objective of this study is:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2016
Date type not reportedThis date has not been verified as actual or estimated.
January 17, 2017
Actual (reported)March 3, 2017
Actual (reported)December 2018
Actual (reported)December 2019
Actual (reported)Probing pocket depth
Measurement periodontal pocket depth at baseline (in millimetres, mm)
At baseline only (0 months)
Attachment level
Measurement of attachment level at baseline (in millimetres, mm)
At baseline only (0 months)
Bleeding on probing
Proportion of bleeding sites on probing at baseline (in percentage, %)
At baseline only (0 months)
Radiographic bone loss
Proportion of bone loss in relation to total root length at baseline. (in percentage, %)
At baseline only (0 months)
Response to treatment: Probing pocket depth
From baseline (0 months) to follow-up (24 months)
Response to treatment: Attachment level
From baseline (0 months) to follow-up (24 months)
Response to treatment: Bleeding on probing
From baseline (0 months) to follow-up (24 months)
Response to treatment: Microbiological assay
From baseline (0 months) to follow-up (24 months)
Response to treatment: GCF
From baseline (0 months) to follow-up (24 months)
All children will be offered an oral hygiene and tooth scaling and polishing session. For children affected by periodontal disease, subgingival debridement will also be performed according to needs, with the aim to disrupt the subgingival biofilm responsible for the onset and progression of the periodontal pathology. This can be accompanied, when appropriate, by the use of local anaesthesia and adjunctive antimicrobials (systemic or locally applied subgingivally), according to the clinical presentation and the child's medical conditions. In addition, when required, nitrous oxide sedation (NOS) could be used before treatment. Caries will be treated as necessary (shared care with the general dental practitioners / community dental services). Children with mucosal lesions requiring treatment will be given a letter for their GDP suggesting referral to a collaborating expert in Oral Medicine (Prof. Stephen Porter).
For children affected by periodontal disease, oral hygiene advice, non surgical periodontal treatment will also be performed according to needs. This can be accompanied, when appropriate, by the use of local anaesthesia and adjunctive antimicrobials (systemic or locally applied subgingivally), according to the clinical presentation and the child's medical conditions. Accurate supra- and sub-gingival removal of calculus and dental plaque will be performed both with ultrasonic and/or manual instruments. The necessary sub-gingival debridement will be performed in 1 to 4 visits (either full mouth treatment, half-mouth treatment or quadrant-wise treatment) depending on patient preference and practical considerations, using manual (Gracey curettes, Hu-Friedy) and ultrasonic devices (EMS). .
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Center for Oral Clinical Research, Queen Mary, University of London
London, Greater London, E1 2AD, United Kingdom
Dental and Maxillofacial Department, Great Ormond Street Hospital for Children
London, WC1N 3JH, United Kingdom
Luigi Nibali, PhD
Queen Mary University of London
50 participants (actual enrollment reported by the registry).
First Submitted
January 17, 2017
First Posted
March 3, 2017
Study Start
December 2016
Date type not reportedThis date has not been verified as actual or estimated.
Microbiological assay
Microbiological analysis with next generation sequencing of the 16s rRNA metagenome at baseline. (Proportion of specified microbes present in sample at baseline)
At baseline only (0 months)
GCF
Gingival crevicular fluid inflammatory markers (Proportion specified inflammatory markers present in sample at baseline)
At baseline only (0 months)
Contact the study team to confirm eligibility.
Primary Completion
December 2018
Actual (reported)Study Completion
December 2019
Actual (reported)Last Updated
November 14, 2022
Record last verified: 2016-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: